SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001213900-24-031600
Filing Date
2024-04-09
Accepted
2024-04-09 16:10:26
Documents
5
Period of Report
2024-05-24

Document Format Files

Seq Description Document Type Size
1 PROXY STATEMENT ea0200088-01.htm DEF 14A 1787782
2 GRAPHIC tflowchart_001.jpg GRAPHIC 197280
3 GRAPHIC tproxy_001.jpg GRAPHIC 1141375
4 GRAPHIC tproxy_002.jpg GRAPHIC 823363
5 GRAPHIC trelmada_logo.jpg GRAPHIC 58300
  Complete submission text file 0001213900-24-031600.txt   4847937
Mailing Address 2222 PONCE DE LEON BLVD. 3RD FLOOR CORAL GABLES FL 33134
Business Address 2222 PONCE DE LEON BLVD. 3RD FLOOR CORAL GABLES FL 33134 646 876 3459
RELMADA THERAPEUTICS, INC. (Filer) CIK: 0001553643 (see all company filings)

IRS No.: 455401931 | State of Incorp.: NV | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-39082 | Film No.: 24832826
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)